RxDoctor Payments Data

Robin Harding, MD

Family Medicine · Madisonville, TNNPI 1881823136

Payments from drug & device makers

$860in general payments, 2019–2025

Across 42 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$159
  • AbbVie$114
  • AstraZeneca$95
  • Welch Allyn$92
  • Baxter Healthcare$86
  • Boehringer Ingelheim$78
  • plus $236 from 9 others

What the payments were for

  • Food & beverage$65076%
  • Education$324%
  • Other$17721%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$860 in reported general payments places this provider in the 55th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$4,465
Medicare patients
62
Services billed
339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$54,716
JanuviaSitagliptin Phosphate29$36,491
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$34,613
EliquisApixaban37$33,885
TrulicityDulaglutide29$32,085
JardianceEmpagliflozin16$26,466
MounjaroTirzepatide13$22,457
TradjentaLinagliptin12$18,783
Lantus SolostarInsulin Glargine,hum.Rec.Anlog59$10,789
LantusInsulin Glargine,hum.Rec.Anlog25$5,898
Spiriva RespimatTiotropium Bromide11$5,746
Insulin Lispro Kwikpen U-100Insulin Lispro12$2,212
Omeprazole120$2,202
Albuterol Sulfate HfaAlbuterol Sulfate84$2,198
Duloxetine Hcl59$1,863

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$159$54,71647 claims
Lilly USA, LLCTrulicity, Mounjaro$30$54,54242 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$78$50,99539 claims
PfizerEliquis$63$33,88537 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Madisonville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →